<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Lang-Muritano, Mariarosaria</dc:creator>
  <dc:creator>Sproll, Patrick</dc:creator>
  <dc:creator>Wyss, Sascha</dc:creator>
  <dc:creator>Kolly, Anne</dc:creator>
  <dc:creator>Hürlimann, Renate</dc:creator>
  <dc:creator>Konrad, Daniel</dc:creator>
  <dc:creator>Lauber-Biason, Anna</dc:creator>
  <dc:date>2018-10-01</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Estrogen resistance due to mutations in the estrogen receptor α gene (ESR1) has  been described in men and women and is characterized by osteoporosis, delayed  bone age and continuous growth in adulthood, and delayed puberty and multiple  ovarian cysts in women. Although mutations in the estrogen receptor β gene ESR2  were found in 46, XY patients with differences of sex development, no genetic variants  of ESR2 were linked to gonadal defects in women.Settings and Patient: Here we  describe a 16-year-old female patient who came to our tertiary care hospital with  complete lack of estrogen action, as demonstrated by absent breast development,  primary amenorrhea, and osteoporosis, resembling patients with ESR1 mutation.  However, her gonads were clearly abnormal (streak), a finding not observed in ESR1-  deficient patients.Design: To gain insights into the molecular consequences of the  ESR2 defect, whole exome sequencing and extensive functional transactivation  studies in ovarian, bone, and breast cells were conducted, with or without the natural  activator of estrogen receptors, 17β-estradiol.Results: We identified a loss-of-function  heterozygous mutation of a highly conserved residue in ESR2 that disrupts estradiol-  dependent signaling and has a dominant negative effect, most likely due to failure to  interact with its coactivator, nuclear coactivator 1.Conclusions: This is a report of a  loss-of-function mutation in the estrogen receptor β in a young woman with complete  ovarian failure, suggesting that ESR2 is necessary for human ovarian determination  and/or maintenance and that ESR1 is not sufficient to sustain ovarian function in  humans.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/307282</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/307282/files/bia_eoc.pdf</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/307282/files/bia_eo_sm.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1210/jc.2018-00769</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>The Journal of Clinical Endocrinology &amp; Metabolism. - 2018, vol. 103, no. 10, p. 3748–3756</dc:source>
  <dc:subject>info:eu-repo/classification/udc/57</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">Early-onset complete ovarian failure and lack of puberty in a woman with mutated estrogen receptor β (esr2)</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
